FGF2 and lymphedema: Their results showed that mice treated with bFGF had an improvement in lymphedema (smaller edema volume and earlier decrease in the intensity of indocyanine green fluorescence) and greater lymphangiogenesis (increased lymphatic vessels density and expression of VEGF-C) compared to the control group [16].